Source: Virtual Congress 2020 – Chronic respiratory diseases and their origins in early life: how physiology meets clinical medicine
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
M. Faner Canet (Barcelona, Spain). Pulmonary diseases and ageing. Virtual Congress 2020 – Chronic respiratory diseases and their origins in early life: how physiology meets clinical medicine

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary vascular diseases Source: ERS Skills Course 2016 Year: 2016 Pulmonary vascular diseases Source: ERS Course 2015 Year: 2015 Pulmonary hypertension: a paradigm for rare pulmonary diseases Source: Eur Respir Rev, 26 (146) 170120; 10.1183/16000617.0120-2017 Year: 2017 Pulmonary hypertension in interstitial lung diseases Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009 Pulmonary vascular disease Source: HERMES Summer School 2014 - Educational material Year: 2014 Pulmonary hypertension and cardiovascular diseases in ILD Source: ERS Course 2016 Year: 2016 Pulmonary hypertension and cardiovascular diseases in ILD Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2018 Pulmonary Hypertension and cardiovascular disease in ILDs Source: School Course 2014 - Interstitial lung diseases Year: 2014 Pulmonary involvement in rheumatological diseases in children Source: Virtual Congress 2021 – Paediatric bronchology Year: 2021 Pulmonary hypertension due to lung disease Source: International Congress 2017 – Russian Programme 2017 Year: 2017 Pulmonary hypertension in different interstitial lung diseases Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012 Lung function impairments in systemic diseases Source: Eur Respir J 2004; 24: Suppl. 48, 53s Year: 2004 Updates in pulmonary hypertension and other pulmonary vascular diseases Source: Breathe, 15 (3) 241; 10.1183/20734735.0187-2019 Year: 2019 Candidosis due to treatment pulmonary diseases Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities Year: 2009 Pulmonary arterial hypertension: an autoimmune disease? Source: Eur Respir J 2005; 26: 986-988 Year: 2005 Cardiovascular implications of pulmonary hypertension due to chronic respiratory diseases Source: Eur Respir Monogr 2020; 88: 167-183 Year: 2020 PAH-specific therapies improve survival in patients with pulmonary arterial hypertension associated with connective tissue diseases: A Russian single centre experience Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Pulmonary hypertension correction in patients with chronic obstructive pulmonary disease and essential hypertension Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Non-invasive haemodynamic measurement to detect treatment response in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014